# Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)

> **NCT00204568** · PHASE2 · UNKNOWN · sponsor: **University Hospital Schleswig-Holstein** · enrollment: 117 (estimated)

## Conditions studied

- Sarcoma, Soft Tissue

## Interventions

- **DRUG:** Adriamycin
- **DRUG:** Trofosfamide

## Key facts

- **NCT ID:** NCT00204568
- **Lead sponsor:** University Hospital Schleswig-Holstein
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-08
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2013-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00204568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00204568, "Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00204568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*